Organovo Holdings (Seite 158)

[Mystical75]

- 10 Prozent, was geht`n da ab?

Hab eher auf einen Ausbruch über die 5 US-Dollar spekuliert, gestern Abend sah es ja auch ganz danach aus.

[binda]

Organovo: Keine Chance ohne Risiko

Life Science Unternehmen in frühen Entwicklungsphasen vereinen große Chancen und hohe Risiken.
Von Simone Hörrlein / 14. Mai 201

http://www.goingpublic.de/organov-keine-chance-ohne-risiko/

[binda]

Ob wir darüber noch Details erfahren?


Organovo to Present at the 12th Annual Needham Healthcare Conference
04/25/2013
SAN DIEGO, April 25, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo"), a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications, has been invited to present at the 12th Annual Needham Healthcare Conference, which will be held in New York April 30 through May 1, 2013. Organovo's Chairman and Chief Executive Officer, Keith Murphy, will present on May 1st, at 3:00 p.m.

Needham & Company's 12th Annual Healthcare Conference is a high-impact forum for institutional investors and venture capital firms to hear the latest updates from senior management teams of both public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology and Diagnostics sectors. One-on-one meetings will be available for qualified investors. This conference is by invitation only. The conference will be held at The Westin Grand Central Hotel, 212 East 42nd Street, NY, NY 10017.

[ElfenbeinelaufenschnellermitKo]

Schöner Ausbruch, der sich heute früh schon angedeutet hat.

[binda]

[Sherby]

Video von CBSNews unter:

http://www.cbsnews.com/video/watch/?id=50145767n

lg
sherby

[binda]

Dear Organovo Supporter,

I wanted to reach out to you personally regarding two exciting national media events involving Organovo.

Recently our facility was visited by CBS News. They were here to film a segment on bioprinting/tissue engineering for broadcast on CBS Sunday Morning, which is scheduled on April 28. We anticipate Organovo will have a prominent place in this piece along with an academic perspective from Cornell University and a mention from one of our key strategic partners, Oregon Health & Sciences University.

Check the local listings for times in your area, as this program typically airs early on Sundays. I hope you will find time to catch the broadcast this Sunday. Also, hitting the newsstands on April 30, Organovo has been recognized by Inc. Magazine as one of the 25 Most Audacious Companies today, alongside companies such as Square, Change.org, and Red Bull. You can find an advanced copy on-line by visiting, http://www.inc.com/audacious-companies.

Media interest of this caliber reinforces the value of the progress we are making toward changing the shape of medical research and practice.

Sincerely,
Keith Murphy, CEO



Date Sent: 4/26/2013 9:39:21 AM

[binda]

08.04.2013 | 14:06
(27 Leser) Schrift ändern:
(0 Bewertungen)

PR Newswire · Mehr Nachrichten von PR Newswire
Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
NEW YORK, April 8, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO) the San Diego-based regenerative medicine company focused on using its breakthrough NovoGen 3D human tissue printing technology to create tissue on demand for medical research and therapeutic applications, today announced that their April 4th RetailInvestorConferences.com presentation is now available for on-demand viewing.

LINK: www.retailinvestorconferences.com > click the red "register/ watch event now" button

Organovo, Inc.'s presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.

[Betterway]

Antwort auf Beitrag Nr.: 44.372.987 von lumumba72 am 05.04.13 17:21:15

Ja, genau so ist das. Mehr Informationen wirst du auch von niemandem bekommen. Das ganze ist eine Wette, mehr nicht. Ob da was draus wird, wird die Zukunft zeigen. Wenn nicht, hat man seine Kohle in den Sand gesetzt. That's it !! Gruß B.

[lumumba72]

hmmm

ich hab mir jetzt den gesamten Thread durchgelesen, aber keine Unternehmensanalyse geschweige Bewertungsanalyse gefunden. Es geht hier bisher immer nur um die Frage ob 3D Printing Zukunft hat oder nicht. Aber woher weiß ich denn welches Potenzial die Aktie hat? Woher weiß ich denn, ob aktuell 0,1 Dollar oder 5 Dollar oder 10 Dollar oder 50 Dollar ein sinnvoller Kurs ist?

Wie stark muss Organovo noch investieren, wie viele Kapitalerhöhungen durchführen? Welche Umsätze und Margen sind sagen wir in drei Jahren denkbar? Wie hoch ist das Risiko einer Pleite, denn die Bilanz sieht aj eher fürchterlich aus, auch wenn das bei einem jungen Wachstumsunternehmen nicht unnormal ist.

Was ich sagen will ... wie soll denn ein normaler Mensch beurteilen, wann die Aktie kaufenswert ist und wann nicht? Die Infos hier im Thread bringen mich nicht weiter.